2017 ACVO "Best" Manuscript Award Winners

IMG_3031_Edelmann1.JPG

Best Clinical Research Manuscript Recipient:
Dr. Michele Edelmann for "Adjunctive autologous platelet rich plasma treatment following diamond burr debridement for canine spontaneous chronic corneal epithelial defects - a randomized controlled clinical trial"
This paper evaluated the effects of adjunctive treatment with platelet rich plasma on corneal re-epithelialization, vascularization, and fibrosis in dogs with spontaneous chronic corneal epithelial defects. In this population of dogs no significant difference was found, but the treatment was well tolerated.

 

Best Basic Science Manuscript Recipient: (Not pictured)
Dr. Todd Marlo for "Altering equine corneal fibroblast differentiation through Smad gene transfer"
The paper describes the use of gene transfer technology to silence profibrotic Smad, overepxress antifibrotic Smad, or a combination of therapies to control TGF-β1-mediated fibrosis in equine fibroblasts. Such therapies could be used in the future to diminish corneal scarring. Read the full manuscript here.

IMG_1097.JPG

Best Case Report Manuscript Recipient:
Dr.  Ben Bergstrom for "Canine Panuveitis: a retrospective evaluation of 55 cases (2000-2015)"
This paper describes the most common etiologies of panuveitis in a group of dogs, patient response to therapy, and visual outcome. Dogs with idiopathic/immune-mediated panuveitis tended to respond more favorably to medical therapy than dogs with infectious panuveitis. Visual outcome was favorable in those dogs that responded to initial medical therapy, but long-term therapy was required in many dogs to maintain vision and prevent recurrence of disease. Read the full manuscript here.


2018 ACVO "Best" Manuscript Awards

The 2018 ACVO Resident Manuscript Awards submissions will open May, 2018. Please check back at that time.

Step 1. Eligibility (all of the following must be met):

  • A resident in an ABVO approved residency training program or an individual who has completed his/her ABVO approved residency within 18 months of the application deadline
  • Applicant must be first author on the manuscript
  • Manuscript research must have been conducted as part of the applicant’s ABVO approved residency program
  • Manuscript must be published, in press, or accepted without further revisions
    • Note: manuscripts that are “accepted” but with “minor” or “major revisions” are not eligible for consideration

Step 2. Required Application Materials

 Please submit the following materials to the ACVO office by email:

  • Cover letter (addressed to the ACVO Executive Director)
  • Full manuscript and citation, including DOI, where available
  • Award category in which the manuscript is being entered: 1) Basic Science, 2) Clinical Research, or 3) Case Report or Review Article
  • Name of ABVO approved residency program and date (MM/DD/YYYY) that the applicant finished or will finish his/her program
  • A statement affirming that the manuscript research was conducted as part of the applicant’s ABVO approved residency program

Note: Cover letter must also be signed by both the applicant and the Supervising Diplomate and a copy of the manuscript must be sent with the cover letter. Manuscripts in press or accepted without further revision – a copy of the final acceptance letter must be included.

If a publisher’s version is not yet available, the final peer-revised manuscript should be submitted (Note: the NIH defines “final peer-revised manuscript” as follows: "The Investigator’s final manuscript of a peer-reviewed paper accepted for journal publication, including all modifications from the peer review process." (http:///publicaccess.nih.gov/FAQ/htm)